Rifampicin, an important antibiotic, is manufactured by chemical conversion of rifamycin S which is obtained by the chemical modification of rifamycin B. Rifamycin B is a product of Nocardia mediterranei fermentations. The chemical conversion of rifamycin B to rifamycin S has many disadvantages: Strong acidic conditions are required, heavy foam formation accompanies transformation and the yields are low. This review highlights the developments in alternative, biochemical transformations using enzymes and cells; the main focus is on transformations carried out by rifamycin oxidase.
Introduction
Chemical or biochemical transformation of naturally produced antibiotics can potentially be used to alter some of the characteristics of the natural substances.
Changes in antimicrobial activity, spectrum of action, oral absorption, toxicity and allergenic responses may be achieved. A commercially used example of such a transformation is the conversion of penicillins (predominantly benzyl penicillin) to 577 U.C. BANERJEE etal.
6-amino penicillanic acid, 6-APA, which is a precursor for other semi-synthetic penicillins. The enzyme penicillin acylase produced by Escherichia coli, other bacteria and fungi [1] , is the basis of this conversion which involves selective hydrolysis of the amide bond in the penicillin side-chain.
Rifampicin, a powerful antibiotic against certain important diseases, is currently produced by a scheme utilising fermentation followed by chemical conversion: The relatively inactive precursor, rifamycin B, is produced by Nocardia medilerranei in submerged culture; it is converted to the active rifamycin S in a chemical process. The low pH requirements of the chemical conversion necessitate expensive acid-resistant equipment, the yields are low and excessive foam formation causes operational problems. As a result, rifampicin is one of the more expensive antibiotics. In view of the shortcomings of the chemical conversion step, alternative biotransformations of rifamycin B to S have been investigated [2, 3] .
Here we review these biotransformation methods based in several forms of biocatalysts: immobilized enzymes, growing and resting whole cells, and pretreated cells.
Rifamycins
From the culture filtrate of the original strain of N. mediterranei, seven metabolites (rifamycins A-E, G and Y) were isolated [4, [5] [6] [7] . The structures of these natural rifamycins are shown in Figure 1 [8] . Of these, rifamycin B was chosen for development because of its stability, ease of purification and solubility at physiological pH's. Addition of barbiturates to the fermentation media was used to dramatically alter the product mix, favouring the formation of rifamycin B, and hence establishing a practical method for its production [9, 10] . Rifamycin B was demonstrated to be microbiologically inactive [11] ; its apparent activity depended on its transformation into active products in test cultures or in body fluids. The transformation products (rifamycin O, SV and S) were isolated and found to be microbiologically very active. Due to its good in-vivo activity, tolerability and solubility properties, rifamycin SV was chosen for further studies. Rifamycin SV has been marketed in several countries for the treatment of infections from gram- positive bacteria, but it is poor in anti-tuberculotic activity. Hundreds of compounds were synthesized from rifamycin B, O and S with the aim of obtaining a product superior to rifamycin SV in at least two respects: activity by oral administration and greater efficacy in curing tuberculosis. These goals were attained with rifampicin which is now widely used for the treatment of leprosy, tuberculosis and several other infectious diseases [12] , Rifampicin is at present also used in several other infections, notably in severe infections by Staphylococci resistant to I[}-lactam antibiotics and infections caused by intracellular bacteria.
Rifamycin SV, rifamide and rifampicin are the rifamycin group of antibiotics which are industrially produced and used as drugs. Their minimum inhibitory concentration (MIC) values against a range of organisms are given in Table 1 [11] .
Rifampicin is also effective against trachoma and inhibits certain viruses and experimental tumours. Other semi-synthetic rifamycins are 27-demethyl-rifamycin SV and, 25-deacetyl and 27-demethyl rifamycin B. Rifamyein S is of considerable [11] .
economic importance because it is a precursor for the majority of semi-synthetic rifamycin antibiotics. Although, it is possible to produce the biologically active rifamycin S by fermentation from a blocked mutant, its yield is low compared to that of rifamycin B. Addition of sodium diethyl barbiturate to the fermentation medium results essentially in the formation of a single product, rifamycin B.
Biotransformation of Rifamycins
Biotransformation of rifamycin was first reported by Lancini et al. [13] mediterranei transformed the quinone ring of rifamycin S into pyrone ring of rifamycin G [7] . Later, Ghisalba et al. showed that a strain of N. mediterranei N813 (rifamycin B producer) partially transformed protorifamycin I to protorifamycin W [17] . The formation of a small amount of rifamycin B from protorifamycin I could also be detected [17] . transforming rifamycin S to rifamycin SV [19] . This transformation was NADH dependent, but was not specific for the rifamycin biosynthetic pathway [19] . The reduction was probably due to the reducing conditions of the cells.
The above cited biotransformation studies were carried out to elucidate the biosynthetic pathways of rifamycins. known that 100 g of rifamycin B yields 92 g of rifamycin S. From the action of rifamycin oxidase on rifamycin B, it seems that substituted hydroquinone moiety of rifamycin B is converted to quinone form of rifamycin B, Le., to rifamycin S.
Bioprocesses for rifamycin S production
The proposed organic reaction mechanism of this transformation is shown in Figure 3 .
The same group of workers also published the isolation procedure of Monocillium sp. and its morphological and culture characteristics [20] . They further demonstrated that rifamycin S can be prepared in high yield by microbial transformation of rifamycin B [20] .
In 1989 Vohra et al. reported a highly active extracellular rifamycin oxidase from Curvularia lunata var aeria [3] . This enzyme could effectively transform rifamycin B to S. The time course of this conversion, monitored by HPLC [21] ,
showed rapid consumption of rifamycin B, with 90% of it disappearing within the first twenty minutes of incubation. The production of rifamycin O was correspondingly fast and it underwent spontaneous hydrolysis to rifamycin S.
Within an hour all the rifamycin B was converted to rifamycin O and most of the latter was hydrolysed to rifamycin S.
Production of rifamycin oxidase
In order to increase the intracellular rifamycin oxidase production by Humicola sp., biochemical engineering studies were conducted by Kim et al. [22] . The maximum specific enzyme activity in fermentations without pH control was reported to be 9.5 IU/g dry cell, and 15 IU/g dry cell for cells cultured at controlled pH of 8.0 [22] . Rifamycin oxidase production was accompanied by biomass growth [22] . Antifoam (Neorin 202) concentrations lower than 1% (v/v) did not have any significant effect on cell growth or on enzyme productivity [22] .
pH control enhanced cell growth as well as enzyme production. The maximum specific cell growth rate was 0.24 h -1 at a constant pH 7.0, but it was only 0.19 h -1 in absence of pH control. Highest specific enzyme activity and productivity were observed at pH 8.0. No significant repression of enzyme production by high glucose concentrations was apparent up to 60 g/L glucose [22] . At this glucose concentration, 15 IU of enzyme activity per gram dry cell weight were obtained (with pH control) and total enzyme production was 300 IU/L.
The effects of different carbon and nitrogen sources and of environmental factors (pH, temperature) on the production of rifamycin oxidase by C. lunata have been studied [23, 24] . Carboxymethylcellulose, yeast extract and peptone (1% w/v, each) and ammonium sulphate (0.04 % nitrogen content) were determined to be the best combination for maximum rifamycin oxidase production [24] . Other synthetic media were also tested, but no growth or enzyme production occurred in those media [23] . When carboxymethylcellulose was used as a carbon source, the organism (C. lunata) formed mycelial type of growth rather than pellet type [23] . With other substrates, pellet type of growth prevailed [23] . Mycelial growth always yielded higher enzyme activity [24] . Enzyme activity was reduced under conditions which led to intraceilular black pigment production. C. lunata could produce high amounts of extracellular rifamycin oxidase within 40-50 hours of fermentation. The enzyme yield was found to be 3400 IU/g (dry weight) cell mass. 
Characteristics of rifamycin oxidase
The characteristics of rifamycin oxidase from Humicola sp. are different from that The catalytic properties of partially purified rifamycin oxidase produced intracellularly by Humicola sp. were reported by Seong et al. [25] . The enzyme was most specific for rifamycin B among the various rifamycin derivatives tested [26] . The substrate specificity of the enzyme was investigated using various substrate analogues, including rifamycin B derivatives and other polyol compounds.
P-hydroxyphenoxyacetic acid and p-hydroquinone which are corresponding structural analogues in the quinonoid moiety, caused a significant decrease in the enzyme activity compared to rifamycin B and rifamycin SV, respectively [25] . The enzyme showed highest catalytic activity on rifamycin B among the various substrates used. The Kin-value of this enzyme from Humicola sp. was found to be 0.05 mM [25] . Substrate inhibition was observed at substrate concentrations above 2 mM. A pH of 7.8 and a temperature of 45 ° C were optimal for enzyme activity, catalytic activity was greatly reduced above this temperature. The rifamycin oxidase activity was strongly inhibited by Fe +2 and Hg +2, but not by other metal ions [25] . Presence of chelating agents such as EDTA did not affect the enzyme activity [25] .
The optimum pH and temperature of rifamycin oxidase from Curvularia lunata are pH 6.5 and 50 °C, respectively [3] . The kinetic constants for the C.
lunata enzyme have also been reported [26] . Under optimal conditions, MichaelisMenten type kinetics were observed [26] ; the K m and Vma x values, with rifamycin B as substrate, were found to be 0.67 mM and 11 IU/mL, respectively [26] . No inhibition of enzyme activity was noted up to 10 mM rifamycin B [26] . The activation and deactivation energies of the partially purified enzyme, calculated from Arrhenius plots, were 5.80 and 35.10 kcal/mole respectively [26] . The C.
lunata rifamycin oxidase activity was inhibited by Fe +2, Ag + and Hg +2, but was not affected by the chelating agent, EDTA [26] .
Biotransformation with soluble enzymes
Reports on biotransformation of rifamycin B to rifamycin S with soluble rifamycin oxidases are very limited. Intracellular rifamycin oxidases from Monocillium sp.
and Humicola sp. were isolated from the cells and purified, but no systematic work was clone to transform rifamycin B to S with the soluble enzyme. Rifamycin B was used as a substrate simply to ascertain enzyme activity; rifamycin S did form in the reaction mixture.
Extracellular, soluble rifamycin oxidase from C. lunata was used by Banerjee et al. for the transformation of rifamycin B to S [27] . The transformation conditions were optimized using partially purified rifamycin oxidase [27] .
Transformation reactions were carried out at 28, 37 and 50 °C, with or without agitation. Incubation temperature, as well as the mixing rate, significantly affected the transformation rate [27] . Although at higher temperatures (37 and 50 ° C), the transformation time (2 hours) was less than at 28 °C (3 hours), for practical purposes, the lower temperature is preferred: Rifamycin oxidase has better thermostability at 28 °C and oxygen (a required reactant) is more soluble in 
Biotransformation with immobilized enzymes
Rifamycin oxidase from C. lunata was immobilized on nylon fibres using glutaraldehyde as the crosslinking agent [28] . An activity of 18 IU/g fibres, with a binding efficiency of 37 %, was achieved. The immobilized enzyme showed an operational stability of 7-days and was protected against thermal inactivation. It exhibited a gm(app) of 2.0 mM. A polyacrylamide-based immobilization procedure has also been described for this enzyme [26] . Various percentages of acrylamide 
Biotransformation with whole cells in suspension
As an enzyme source for industrial applications, whole cell preparations of Humicola sp. were tested by Seong et al. [25] . Banerjee reported the transformation of rifamycin B to rifamycin S using growing and resting cells of C. lunata [26] . The organism could grow in the presence of rifamycin B and simultaneously convert rifamycin B to rifamycin S [26] . With growing cells, rifamycin B was added at the time of inoculation in the medium.
With 1% (w/v) of rifamycin B in the medium, growth of the organism was reduced, but the transformation was completed within 20 hours of inoculation [26] .
In other experiments, cells were grown up to the stationary phase and rifamycin 
Biotransformation with immobilized whole cells
De-fatted whole cells of Humicola sp. with rifamycin oxidase activity have been immobilized by copolymerization with acrylamide for use in biotransformations of rifamycin [31] . The enzyme activity remaining after the immobilization step was ~50 % of the initial activity. The recovery of activity declined with increasing cell volume added into the original mixture [31] . This may have been due to increase in mass transfer resistances, or, to overpacking of the polyacrylamide gel matrix with cells. The optimal reaction pH for the immobilized, acetone de-fatted, cells was pH 7.8, while the optimal temperature for both free and immobilized defatted whole cells was found to be 50 ° C. Experiments were conducted at a lower temperature of 40 ° C to reduce enzyme inactivation. No appreciable activity loss occurred for the immobilized acetone de-fatted cells during one-month storage at 4 °C and pH 7.8 [30] . The half life of the treated cells at 40 °C and pH 8 was ca.
8-days.
The Michaelis-Menten constants, Km(app) , and the substrate inhibition constant, Kin(app), of the immobilized, acetone de-fatted, cells were found to be 0.6 mM and 19.6 mM, respectively [31] . The Kin-value of the acetone de-fatted cells in free suspension was calculated at 0.3 mM. The simplest mechanism that could explain such a kinetic behaviour was suggested [32] to be the following:
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Using the steady state approximation in the above cited scheme, the overall rate of product formation may be shown to be In another preparation, the acetone de-fatted cells were immobilized on cellulose acetate [33] . The optimum pH and temperature of this catalyst were found to be pH 7.2 and 50-55 °C, respectively. Compared to the free enzyme, the immobilized preparations were less sensitive to temperature and pH changes.
Twenty percent of the enzyme activity was recovered when the treated cells were immobilized on 3 mm beads [33] . Recovery of the immobilized enzyme activity increased as the bead size became smaller. Mass transfer limitations were concluded to be the main reason for lower activity of the immobilized enzyme [33] . The optimal loading of the acetone treated cell powder for cellulose acetate beads was one gram powder in 50 mL acetone/dimethylsulfoxide (3:2 v/v) mixture [33] . A fluidized bed system with immobilized whole cells ofHumicola sp. was used also by Lee el al. [34] . A linear relationship between the loading of the immobilized whole cells and conversion in both batch and continuous operations were found [34] ; however, the conversion efficiency was higher in the batch mode for any given residence time [34] .
Moreover, the aeration effect on the reaction rates in continuous operation was different from that in batch operation. Among the two reactor geometries used, the one which produced better mixing also gave 10 % better yield.
For the biotransformation with immobilized whole cells in a rotating packed disc reactor (RPDR), Chung et al. found that the initial reaction rate and the total productivity were dependent upon the degree of submergence of the discs [35] .
The optimal submergence was 0.5; the rotational speed of the disc did not affect the conversion very much. Higher conversions were attained with longer residence times; however, the productivity declined with increasing residence times. Higher The latter system has important processing advantages and either partially purified enzyme, or crude extracts of C. lunata can be used. Immobilized rifamycin oxidase preparations can also be employed with the advantages of greater stability, reusability and productivity. It is now clear that several biotransformation options may be used to prepare rifamycin S from rifamycin B. In view of the importance of rifamycin S as a key intermediate for the preparation of many semi-synthetic rifamycin derivatives of therapeutic value, further process improvements and scaleup considerations need to be investigated.
